Seattle Genetics | Action



Action Changement Date
AbbVie USD 4.95B 13M 2025-12
Acadia Pharmaceuticals USD 29.1M 2.97M 2025-09
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Amgen USD 6.22B 121M 2025-12
Astellas Pharma JPY 297.26B 9.92B 2025-03
Bayer EUR 12.33B 221M 2025-09
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.38B 42M 2025-09
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eisai JPY 236.46B 9.14B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Exelixis USD 27.4M 3.92M 2025-09
Genmab DKK 13M 1000K 2025-06
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Incyte USD 101.06M 17.61M 2025-12
Insmed USD 132.07M 11.1M 2025-12
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
MacroGenics USD 8.75M 530K 2025-09
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1.08B 83.13M 2025-09
Takeda JPY 1.41T 107.71B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12


Seattle Genetics Action - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.